What is ONGLYZA (saxagliptin)?
ONGLYZA (saxagliptin) is a prescription medicine used along with diet and exercise
to lower blood sugar in adults with type 2 diabetes.
ONGLYZA (saxagliptin) should not be used to treat people with type 1 diabetes or diabetic ketoacidosis
(increased ketones in the blood or urine).
If you have had inflammation of the pancreas (pancreatitis), it is not known if
you have a higher chance of getting pancreatitis while taking ONGLYZA (saxagliptin).
Important Safety Information
Do not take ONGLYZA (saxagliptin) if you are allergic to any of its ingredients.
Serious allergic reactions can occur with ONGLYZA (saxagliptin) and may include swelling of the
face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives,
rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA (saxagliptin)
and contact your doctor right away.
Serious side effects can happen to people taking ONGLYZA (saxagliptin), including inflammation
of the pancreas (pancreatitis) which may be severe and lead to death. Before taking
ONGLYZA (saxagliptin), tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism,
or high triglyceride levels. Stop taking ONGLYZA (saxagliptin) and contact your doctor right away
if you have pain in your stomach area (abdomen) that is severe and will not go away.
The pain may be felt going from your abdomen through to your back. The pain may
happen with or without vomiting. These may be symptoms of pancreatitis.
When ONGLYZA (saxagliptin) is used with certain other diabetes medicines to treat high blood sugar,
such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is
higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache,
rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions
for treating low blood sugar.
When ONGLYZA (saxagliptin) is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone,
to treat high blood sugar, peripheral edema (fluid retention) may become worse.
If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles,
call your doctor.
The most common side effects with ONGLYZA (saxagliptin) include upper respiratory tract infection,
urinary tract infection, and headache.
Your doctor should test your blood to measure how well your kidneys are working
before and during treatment with ONGLYZA (saxagliptin). You may need a lower dose if your kidneys
are not working well.
Tell your doctor if you start or stop taking other medications, including antibiotics,
antifungals or HIV/AIDS medications, as your doctor may need to change your dose
of ONGLYZA (saxagliptin).
Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant
You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch,
Please click here for Medication Guide, and click here for US Full Prescribing Information for ONGLYZA (saxagliptin).
This product information is intended for US customers only.
©2014 AstraZeneca. All rights reserved.
ONGLYZA is a registered trademark of the AstraZeneca group of companies.
1806604‐3013901 Last updated 6/13